RVLPQ — RVL Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $38.61m
- $49.72m
Annual cashflow statement for RVL Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -110 | -271 | -79.6 | -82.8 | -51.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 107 | 290 | 79.2 | 27.6 | 9.21 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -25.9 | -15.8 | -1.86 | -7.46 | 4.39 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 37.6 | 33.6 | 17.6 | -54.7 | -37.8 |
| Capital Expenditures | -4.14 | -4.04 | -3.13 | -1.78 | -0.752 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.01 | 0.017 | 0.05 | 118 | 0.878 |
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.13 | -4.02 | -3.08 | 116 | 0.126 |
| Financing Cash Flow Items | -0.002 | 0 | -0.53 | 51.2 | 19.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.6 | -4.69 | 3.68 | -135 | 41.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 36.1 | 25 | 18.2 | -73.6 | 4.1 |